IVZ vs CRBG
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IVZ · Invesco$27.08 ▲ 0.00%
CRBG · Corebridge Financial$34.09 ▼ 0.44%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IVZ +18.2%
- CRBG +16.9%
Head to head
| Metric | IVZ | CRBG |
|---|---|---|
| Price | $27.08 | $34.09 |
| Change today | ▲ 0.00% | ▼ 0.44% |
| Market cap | $11.90B | $14.95B |
| Return, 3 months | -14.1% | -0.5% |
| Return, year to date | +5.4% | +16.0% |
| Return, 1 year | +19.6% | +17.7% |
| P/E (TTM) | -39.2 | 7.6 |
| P/B | 1.2 | 2.4 |
| P/E percentile vs own 5y | 6th | 58th |
| Dividend yield | 3.14% | 2.90% |
| Revenue growth (YoY, latest qtr) | +20.5% | +26.3% |
| Net profit growth (YoY) | +71.7% | +100.3% |
| Gross margin | 35.8% | – |
| Operating margin | -7.1% | – |
| Net margin | -4.5% | 4.6% |
| Return on equity | -3.0% | 7.9% |
| Analyst target vs. price | +34.0% | +19.9% |
| Analyst buy share | 45% | 80% |
| RSI (14) | 38 | 45 |
| 30-day volatility | 37.5% | 30.1% |
| Max drawdown, 1 year | -22.0% | -30.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- CRBG is the largest of the group by market value.
- IVZ has returned the most over the past year.
- IVZ carries the lowest trailing P/E.
- IVZ pays the highest dividend yield.
- CRBG is growing revenue fastest.
- CRBG keeps the most profit per dollar of sales.
- CRBG has been the calmest stock over the last 30 days.